Sjögren's disease trials in Czechia

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Czechia
  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  Where

  Brno-Sever, Prague, Prague 2

  Age

  18 years and over

  People

  570 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07621809 · EU 2025-522271-29-00